Pulsenmore Ltd

Pulsenmore Ltd(PLSM)股票分析

$2.570

-0.096 (-3.75%)收盘时

Loading chart…
High
2.660
Open
2.610
VWAP
2.59
Vol
23.67K
Mkt Cap
Low
2.530
Amount
61.22K
EV/EBITDA, TTM
0.00

Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products.

AI analysis of Pulsenmore Ltd (PLSM)

sell

Pulsenmore Ltd is not a good buy right now due to its extremely low RSI of 17.754, indicating oversold conditions, and a staggering year-to-date change of -72.80%. These factors suggest significant downward momentum and a lack of investor confidence. The forward P/E ratio is also 0, indicating no earnings growth expected in the near term, which is a red flag for long-term investors. The main risk is the negative sentiment surrounding the stock, as it has experienced a 12.59% decline over the last five days, reflecting ongoing volatility and uncertainty.

估值指标

The current forward P/E ratio for Pulsenmore Ltd (PLSM) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

Whales holding PLSM

A

Aquamarine Financial (Cayman) Ltd

+ HoldingPLSM

-0.65%

3M Return

事件时间线

2026-07-13 (ET)

07:31:00

Pulsenmore Selected for Israel's Healthcare AI Regulatory Sandbox Program

2026-07-02 (ET)

16:30:00

Company Not Selling Shares, Stockholders Offering 3.125M Shares

2026-06-25 (ET)

08:31:00

Pulsenmore Enters Agreement to Issue 1,562,500 Shares with Institutional Investor

2026-02-13 (ET)

09:40:00

Pulsenmore Ltd. Trading Halted Due to Volatility

2026-02-09 (ET)

07:10:00

Pulsenmore Signs New Agreement with TLC Perinatal

资讯

PLSM FAQ — answered by Alphio AI

Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products. It operates in the Healthcare sector.

Pulsenmore Ltd is not a good buy right now due to its extremely low RSI of 17.754, indicating oversold conditions, and a staggering year-to-date change of -72.80%. These factors suggest significant downward momentum and a lack of investor confidence. The forward P/E ratio is also 0, indicating no earnings growth expected in the near term, which is a red flag for long-term investors. The main risk is the negative sentiment surrounding the stock, as it has experienced a 12.59% decline over the last five days, reflecting ongoing volatility and uncertainty.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始